{"url_path":"/sec/anip/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000056-index.html","accession_number":"0001023024-26-000056","cik":"0001023024","ticker":"ANIP","issuer_name":"ANI PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000056-index.html","primary_entity_key":"0001023024","primary_entity_name":"ANI PHARMACEUTICALS INC"},"word_count":79,"has_tables":true,"body_markdown":"Item 9.01Exhibits\n\n(d)Exhibits\n\nExhibit\nNo.Description\n\n10.1\n[Amended and Restated ANI Pharmaceuticals, Inc. 2022 Stock Incentive Plan](amendedandrestatedanipharm.htm)\n\n104Cover Page Interactive Data File (embedded with the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDated: May 21, 2026ANI PHARMACEUTICALS, INC.\n\n  \n\nBy:/s/ Stephen P. Carey\n\nName:Stephen P. Carey\n\nTitle:Senior Vice President, Finance and Chief Financial Officer"}